PETROS PHARMACEUTICALS INC (PTPI)       2.66  +0.03 (+1.14%)

Company Profile

Petros Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in New York City, New York and currently employs 24 full-time employees. The company went IPO on 2020-12-02. Petros Pharmaceuticals, Inc. is a pharmaceutical company focused on men's health therapeutics with a range of commercial capabilities including sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. The firm is also focused on identifying, developing, acquiring, and commercializing therapeutics for men's health issues, including, erectile dysfunction (ED), endothelial dysfunction, psychosexual and psychosocial ailments, peyronie's disease, hormone health, and substance use disorders. The firm also markets its own line of ED products in the form of vacuum erection device (VED) products through its subsidiaries, Timm Medical, Inc. In addition, its ED products, the Company is focused on identifying and developing other pharmaceuticals to advance men's health, which is H100, which is the topical formulation candidate for the treatment of acute peyronie's disease.

Company Info

PETROS PHARMACEUTICALS INC

1185 Avenue Of The Americas, 3Rd Floor, Suite 570

New York City NEW YORK 10036

P: 19732420005.0

CEO: John D. Shulman

Employees: 24